Hover to zoom
Cognitive / NeuroSynthetic tripeptide (Glu-Asp-Arg)
Pinealon
$49.99
20 mgPinealon is a synthetic tripeptide (Glu-Asp-Arg) belonging to the Khavinson short-peptide bioregulator series, developed from work on pineal and brain tissue extracts.
It appears in laboratory research examining whether very short peptides influence transcriptional activity and cell viability in neuronal culture models under stress conditions.
Research areas
Peptide bioregulator studiesNeuronal cell modelsGene-expression researchPreclinical research
Form: Lyophilized (freeze-dried)
- Compound class
- Synthetic tripeptide (Glu-Asp-Arg)
- Research category
- Cognitive / Neuro
- SKU
- NVR-PINEALON-20MG
- Alternate name
- Pineal peptide
- Appearance
- White lyophilized powder
- Storage
- Store lyophilized at −20 °C. Protect from light and moisture.
Research use only
Strength
20 mg$49.99$2.50/mg
1
$49.99per 20 mg$2.50/mg
For research use only — not for human or animal consumption.
Supplied solely for legitimate laboratory and research purposes. Not for medical or veterinary use, diagnosis, treatment, or prevention of disease.
Research Grade
Batch Documentation
Research Use Only
U.S.-Based Fulfillment
What you should know
More detail on Pinealon.
Analytical values reflect per-lot documentation and appear once a batch is released.
Compound
The bioregulator hypothesis holds that short peptides can enter cells and interact with nucleic acids or chromatin-associated proteins to influence gene expression in a tissue-selective way. Pinealon is studied within that framework, typically in cultured neurons exposed to oxidative or hypoxic stress. The supporting literature comes largely from a limited set of research groups and has seen little independent replication, so findings should be regarded as preliminary. The peptide's small size also makes it a convenient subject for synthesis and stability work.
Peptide class
Synthetic tripeptide (Glu-Asp-Arg)
Mechanism (research context)
Pinealon has been studied in neuronal-culture systems and cognitive-model preclinical work as part of the pineal-associated short-peptide series.
Why it is studied
Pinealon is a reference compound in the short-peptide neuroscience literature associated with pineal-associated regulatory research.
Current areas of research
Peptide bioregulator studiesNeuronal cell modelsGene-expression researchPreclinical research
Topics reflect published preclinical and in vitro research. Reference only — not a claim of clinical outcomes.
Scientific background
Pinealon originates from the same Saint Petersburg gerontology program that produced epithalon and other short-peptide research compounds.
It has been characterized in preclinical neuronal-model literature examining short-peptide regulatory effects.
Related
View all →Related research materials
Pinealon
20 mg · $49.99